Imunon Inc (IMNN) — Strategic Asset Allocation Index

Latest as of September 2023: 13.8%

Imunon Inc (IMNN) has a Strategic Asset Allocation Index of 13.8% as of September 2023. Strategic assets (PP&E of $2.49 Million plus long-term investments of $-) total $2.49 Million, measured against net assets of $18.07 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IMNN net asset quality score to measure how much of total assets are equity-financed.

SAAI

13.8%
Strategic Assets / Net Assets

Strategic Assets

$2.49 Million
PP&E + LT Investments

PP&E

$2.49 Million
USD

Net Assets

$18.07 Million
USD

Imunon Inc Strategic Asset Allocation Index (2018–2022)

This chart shows how Imunon Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the index stands at 13.8%, representing strategic assets of $2.49 Million against net assets of $18.07 Million USD. For live market cap and overall valuation, see IMNN stock market capitalisation.

Annual Strategic Asset Allocation Index for Imunon Inc (2018–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Imunon Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Imunon Inc's book value for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2022 2.4% $704.18K $704.18K $- $29.33 Million ▲ +0.3 pp
2021 2.1% $1.17 Million $1.17 Million $- $55.80 Million ▼ -5.1 pp
2020 7.2% $1.34 Million $1.34 Million $- $18.61 Million ▼ -5.4 pp
2019 12.6% $1.84 Million $1.84 Million $- $14.56 Million ▲ +11.7 pp
2018 0.9% $184.63K $184.63K $- $20.86 Million
pp = percentage points